Lactylation in Gynecological Cancers: Unlocking Metabolic and Epigenetic Secrets

20 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Lactate, once dismissed as waste, is now a star player in cancer research. This video uncovers the fascinating role of lactate and lactylation in gynecological cancers, including ovarian, cervical, and endometrial cancers. Learn how this metabolic byproduct drives a unique post-translational modification, influencing tumor growth, metastasis, and therapy resistance. Discover the enzymes involved in lactylation, such as p300/CBP, HDACs, and Smarca4, and their impact on histone and non-histone proteins. Explore the potential of targeting lactate metabolism and lactylation as a novel therapeutic strategy, with a focus on metabolic interference, lactate transporter inhibition, and immunotherapy combinations.
Understand why lactylation is a critical bridge between metabolism and epigenetics, and how it might hold the key to more effective treatments for gynecological malignancies. Stay tuned for an in-depth look at the latest research and clinical prospects in this exciting field.
Categoria
Oncology
Commenta per primo questo video.

Prossimo